End-payers seek final approval for settlements with Heritage Pharmaceuticals, Apotex in US pricing litigation
MLex Summary: End-payers asked a US federal judge to grant final approval to their settlements with Heritage Pharmaceuticals and Apotex to resolve a multidistrict litigation over generic pharmaceuticals pricing. If approved, Heritage will...To view the full article, register now.
Already a subscriber? Click here to view full article